Cargando…

Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta‐analysis

BACKGROUND: One potential cause of suicide is serotonergic dysfunction. Sex differences have been reported to modulate the effects of serotonergic polymorphisms. Monoamine oxidase A (MAOA) is an enzyme that degrades serotonin and is located on the X chromosome. A previous study indicated that the up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasegawa, Masashi, Tanifuji, Takaki, Okazaki, Satoshi, Otsuka, Ikuo, Shirai, Toshiyuki, Shindo, Ryota, Horai, Tadasu, Mouri, Kentaro, Takahashi, Motonori, Kondo, Takeshi, Ueno, Yasuhiro, Hishimoto, Akitoyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496037/ https://www.ncbi.nlm.nih.gov/pubmed/37202909 http://dx.doi.org/10.1002/npr2.12344

Ejemplares similares

Association of Two Variable Number of Tandem Repeats in the Monoamine Oxidase A Gene Promoter with Schizophrenia
por: Tanifuji, Takaki, et al.
Publicado: (2021)

Accelerated epigenetic aging and decreased natural killer cells based on DNA methylation in patients with untreated major depressive disorder
por: Shindo, Ryota, et al.
Publicado: (2023)

Ribosomal DNA gene copies are increased in blood and brain of Japanese schizophrenia patients
por: Li, Sen, et al.
Publicado: (2023)

Accelerated epigenetic age and shortened telomere length based on DNA methylation in Nicolaides–Baraitser syndrome
por: Shinko, Yutaka, et al.
Publicado: (2022)

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population
por: Shimmyo, Naofumi, et al.
Publicado: (2017)

Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia
por: Okazaki, Satoshi, et al.
Publicado: (2022)

Epigenetic clock analysis of blood samples from Japanese schizophrenia patients
por: Okazaki, Satoshi, et al.
Publicado: (2019)

Loss of chromosome Y in blood, but not in brain, of suicide completers
por: Kimura, Atsushi, et al.
Publicado: (2018)

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients
por: Horai, Tadasu, et al.
Publicado: (2018)

Searching for biomarkers in schizophrenia and psychosis: Case‐control study using capillary electrophoresis and liquid chromatography time‐of‐flight mass spectrometry and systematic review for biofluid metabolites
por: Kim, Saehyeon, et al.
Publicado: (2021)

Investigation of chromosome Y loss in men with schizophrenia
por: Hirata, Takashi, et al.
Publicado: (2018)

Decelerated epigenetic aging associated with mood stabilizers in the blood of patients with bipolar disorder
por: Okazaki, Satoshi, et al.
Publicado: (2020)

PM311. Possible role of CDH13 in nicotine dependence: Investigations on mouse neural progenitors and schizophrenia patients
por: Otsuka, Ikuo, et al.
Publicado: (2016)

Aberrant telomere length and mitochondrial DNA copy number in suicide completers
por: Otsuka, Ikuo, et al.
Publicado: (2017)

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population
por: Otsuka, Ikuo, et al.
Publicado: (2015)

PM322. The risk factors of low bone mineral density in male alcoholic patients: cross-sectional study
por: Horai, Tadasu, et al.
Publicado: (2016)

Epigenetic clock analysis and increased plasminogen activator inhibitor-1 in high-functioning autism spectrum disorder
por: Okazaki, Satoshi, et al.
Publicado: (2022)

The Regulation of Monoamine Oxidase A Gene Expression by Distinct Variable Number Tandem Repeats
por: Manca, Maurizio, et al.
Publicado: (2018)

Genome-wide association studies identify polygenic effects for completed suicide in the Japanese population
por: Otsuka, Ikuo, et al.
Publicado: (2019)

Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
por: Chiuccariello, Lina, et al.
Publicado: (2015)

Mitochondrial DNA Copy Number Raises the Potential of Left Frontopolar Hemodynamic Response as a Diagnostic Marker for Distinguishing Bipolar Disorder From Major Depressive Disorder
por: Tsujii, Noa, et al.
Publicado: (2019)

ABUSE OF MONOAMINE OXIDASE INHIBITORS
por: Ananth, Jambur, et al.
Publicado: (1995)

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study
por: Igeta, Hirofumi, et al.
Publicado: (2019)

Psychological Distress among University Staff before and during the COVID-19 Pandemic
por: Tanifuji, Takaki, et al.
Publicado: (2023)

Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies
por: Naoi, Makoto, et al.
Publicado: (2022)

Amphetamine Derivatives as Monoamine Oxidase Inhibitors
por: Reyes-Parada, Miguel, et al.
Publicado: (2020)

Parameters for Irreversible Inactivation of Monoamine Oxidase
por: Ramsay, Rona R., et al.
Publicado: (2020)

3-Coumaranone derivatives as inhibitors of monoamine oxidase
por: Van Dyk, Adriaan S, et al.
Publicado: (2015)

Monoamine Oxidase B in Renal Cell Carcinoma
por: Hodorová, Ingrid, et al.
Publicado: (2018)

Cardiac monoamine oxidases: at the heart of mitochondrial dysfunction
por: Mialet-Perez, Jeanne, et al.
Publicado: (2020)

Monoamine Oxidase A Promoter Variable Number of Tandem Repeats (MAOA-uVNTR) in Alcoholics According to Lesch Typology
por: Samochowiec, Agnieszka, et al.
Publicado: (2015)

Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study
por: Ito, Takahiro, et al.
Publicado: (2018)

Telencephalon Organoids Derived from an Individual with ADHD Show Altered Neurodevelopment of Early Cortical Layer Structure
por: Zhang, Danmeng, et al.
Publicado: (2023)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Androgen receptor and monoamine oxidase polymorphism in wild bonobos
por: Garai, Cintia, et al.
Publicado: (2014)

Inhibition of Monoamine Oxidase by Stilbenes from Rheum palmatum
por: Wei, Bo, et al.
Publicado: (2016)

Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?
por: Sommer, Natascha, et al.
Publicado: (2021)

Recent advances on the role of monoamine oxidases in cardiac pathophysiology
por: Kaludercic, Nina, et al.
Publicado: (2023)

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain
por: Cai, Lu, et al.
Publicado: (2016)

Methylxanthines Inhibit Primary Amine Oxidase and Monoamine Oxidase Activities of Human Adipose Tissue
por: Haj Ahmed, Wiem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7doi67d2lt3q61e3j75mthdm8l